While we observed a significant impact of the cGAS-STING pathway on podocyte damage in glomerular diseases of both metabolic (DKD) and non-metabolic (AS and FSGS) origin, the mechanism behind it remains unclear. This evidence concerns the gene STING1 and diabetic kidney disease.